Xie, F., Yun, H., Bernatsky, S., & Curtis, J. R. (2016). Risk for Gastrointestinal Perforation among Rheumatoid Arthritis Patients receiving Tofacitinib, Tocilizumab, or other Biologics. Arthritis Rheumatol.
Styl ChicagoXie, Fenglong, Huifeng Yun, Sasha Bernatsky, a Jeffrey R. Curtis. "Risk for Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologics." Arthritis Rheumatol 2016.
Citace podle MLAXie, Fenglong, Huifeng Yun, Sasha Bernatsky, a Jeffrey R. Curtis. "Risk for Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologics." Arthritis Rheumatol 2016.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..